Introduction Mounjaro, a once-weekly injectable medication developed by Eli Lilly and Company, has become a focal point in the treatment of type ...

Introduction Mounjaro, a once-weekly injectable medication developed by Eli Lilly and Company, has become a focal point in the treatment of type ...

Introduction Ozempic, a medication developed by Novo Nordisk, has gained significant attention since its approval in 2017 for the management of type ...